| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 10/02/2002 | CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 10/02/2002 | CN1371911A Fluoalkyl phosphate and preparation process thereof |
| 10/01/2002 | US6458960 Sulfonamide derivatives |
| 10/01/2002 | US6458959 Anti-herpesvirus compounds and methods for identifying, making and using same |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458785 Aids therapy |
| 10/01/2002 | US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf). |
| 10/01/2002 | US6457303 Wide variety of corresponding analogs and homologs. |
| 10/01/2002 | CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists |
| 10/01/2002 | CA2009925C Method for enhancement of chemiluminescence |
| 09/27/2002 | CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 09/26/2002 | WO2002075318A2 Neurofibrillary labels |
| 09/26/2002 | WO2002074752A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074750A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074749A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074747A1 Farnesyltransferase inhibitors |
| 09/26/2002 | WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient |
| 09/26/2002 | WO2002074268A2 Dyeing compositions for the dyeing of keratin fibres, comprising heterocyclic hydrazone compounds |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2002028810A3 Retinoids for the treatment of emphysema |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2001052847A8 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 09/26/2002 | US20020137779 Use of L-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes |
| 09/26/2002 | US20020137778 Anticancer, antiarthritic, and antiinflammatory agents |
| 09/26/2002 | US20020137776 Therapeutic and prophylactic agents for neoplasms |
| 09/26/2002 | US20020137740 CRF (corticotropin releasing factor) antagonists; 4-(2-Chloro-4-methoxyphenyl)-5-methyl-2-(N-(5-ethoxy-carbonyl-2 -methoxyphenyl)-N-propylamino)thiazole for example |
| 09/26/2002 | US20020137068 Reagents for labeling biomolecules having aldehyde or ketone Moieties |
| 09/26/2002 | CA2444526A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2430619A1 Farnesyltransferase inhibitors |
| 09/25/2002 | EP1243584A1 Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide |
| 09/25/2002 | EP1243580A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use |
| 09/25/2002 | EP1243266A1 Solid preparations for oral use |
| 09/25/2002 | EP1242397A1 Trans olefinic glucokinase activators |
| 09/25/2002 | EP1242390A1 Method for production of 1,3-disubstituted 2-nitroguanidines |
| 09/25/2002 | EP1001951B1 Thiazole derivatives, method for their production and use |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/25/2002 | CN1371360A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455566 Substituted 1-aryl-3-heteroaryl-thioureas (or isothioureas) as antiatherosclerotic agents |
| 09/24/2002 | US6455555 Photosensitizing dye that is a quinolinium- or thiazolium-methine dye |
| 09/24/2002 | US6455550 N-alkanoylphenylalanine derivatives |
| 09/24/2002 | US6455528 Tumor necrosis factor antagonist and/or interleukin promoter; antiallergens, antiinflammatory agents; autoimmune disease treatment |
| 09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | CA2246584C Method of treating tourette's syndrome |
| 09/19/2002 | WO2002072858A2 Degradation of epothilones and ethynyl substituted epothilones |
| 09/19/2002 | WO2002072568A1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 09/19/2002 | WO2002072564A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 09/19/2002 | WO2002072543A2 Rxr activating molecules |
| 09/19/2002 | WO2002072145A1 Remedies for depression containing ep1 antagonist as the active ingredient |
| 09/19/2002 | WO2002072009A2 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 09/19/2002 | WO2001072702A3 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/19/2002 | US20020133019 Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and vivo imaging and prevention of amyloid deposition |
| 09/19/2002 | US20020133005 Heterocyclic compounds and medical use thereof |
| 09/19/2002 | US20020132836 Compounds and methods for modulating CCR4 function |
| 09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
| 09/19/2002 | US20020132816 Estrogen agonists/antagonists for preventing breast cancer |
| 09/19/2002 | US20020132807 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/19/2002 | US20020132797 DNA-cleaving antitumor agents |
| 09/19/2002 | US20020132794 Compounds and methods for inhibition of HIV and related viruses |
| 09/19/2002 | DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2473156A1 Rxr activating molecules |
| 09/19/2002 | CA2440374A1 A pharmaceutical composition for the treatment of depression comprising the ep1 antagonist as active ingredient |
| 09/19/2002 | CA2440184A1 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 09/19/2002 | CA2437707A1 Degradation of epothilones and ethynyl substituted epothilones |
| 09/18/2002 | EP1241528A2 Radical polymerizable compounds for image forming materials |
| 09/18/2002 | EP1240171A1 Cyclopenteneone derivatives |
| 09/18/2002 | EP1240165A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240164A1 Benzazole derivatives and their use as jnk modulators |
| 09/18/2002 | EP1240154A1 Serine protease inhibitors |
| 09/18/2002 | EP1240153A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240144A2 Compound having effect of promoting neuron differentiation |
| 09/18/2002 | EP1239877A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN $g(a) V?$g(b) 3? RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 09/18/2002 | EP0828486B1 Use of pyrrolidine derivatives for treating alcoholism |
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
| 09/18/2002 | CN1370154A Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/17/2002 | US6451988 An azo compound and a metal complex which are synthesized with the naphthol derivative |
| 09/17/2002 | US6451859 C16 unsaturated FP-selective prostaglandins analogs |
| 09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451824 Sulfonylaminocarboxylic acids |
| 09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451821 Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase |
| 09/17/2002 | US6451792 Matrix metalloprotease inhibitors |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/12/2002 | WO2002070624A1 Photochromic material |
| 09/12/2002 | WO2002070494A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 09/12/2002 | WO2002070486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 09/12/2002 | WO2002070469A2 Selective pde3b inhibitors and use of the same in therapy |
| 09/12/2002 | WO2002070468A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 09/12/2002 | WO2002070467A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 09/12/2002 | WO2002069967A1 Percutaneous absorption compositions |
| 09/12/2002 | WO2002069961A1 Il-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
| 09/12/2002 | US20020128481 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/12/2002 | US20020128308 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect. |
| 09/12/2002 | US20020128289 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |